Biogen (BIIB) Q2 2017 Results - Earnings Call Transcript

7/26/17

Biogen, Inc. (NASDAQ:BIIB)

Q2 2017 Earnings Call

July 25, 2017 8:00 am ET

Executives

Matthew Calistri - Biogen, Inc.

Michel Vounatsos - Biogen, Inc.

Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.

Paul McKenzie - Biogen, Inc.

Alfred W. Sandrock, Jr., M.D., Ph.D. - Biogen, Inc.

Jean-Paul Kress - Biogen, Inc.

Analysts

Geoff Meacham - Barclays Capital, Inc.

Eric Schmidt - Cowen & Co. LLC

Umer Raffat - Evercore ISI

Geoffrey C. Porges - Leerink Partners LLC

Ying Huang - Bank of America Merrill Lynch

Aharon Gal - Sanford C. Bernstein & Co. LLC

Robyn Karnauskas - Citigroup Global Markets, Inc.

Matthew K. Harrison - Morgan Stanley & Co. LLC

Alethia Young - Credit Suisse Securities (NYSE:USA) LLC

Terence Flynn - Goldman Sachs & Co. LLC

Michael J. Yee - Jefferies LLC

Cory W. Kasimov - JPMorgan Securities LLC

Jim Birchenough - Wells Fargo Securities LLC

Salim Syed - Mizuho Securities USA, Inc.

Andrew Peters - Deutsche Bank Securities, Inc.

Brian P. Skorney - Robert W. Baird & Co., Inc.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.